Advertisement
Advertisement
NGEN
N
NervGen Pharma Corp. Common stock
3.94
USDSponsored
-0.30
-6.97%
Feb 05, 13:23 UTC -5
Open
NGEN Earnings Reports
Positive Surprise Ratio
NGEN beat 1 of 1 last estimates.
100%
Next Report
Date of Next Report
Apr 01, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.06
Implied change from Q3 25 (Revenue/ EPS)
-100.00%
/--
Implied change from Q4 24 (Revenue/ EPS)
--
/-53.85%
NervGen Pharma Corp. Common stock earnings per share and revenue
On Nov 24, 2025, NGEN reported earnings of -0.06 USD per share (EPS) for Q3 25, beating the estimate of -0.06 USD, resulting in a 0.99% surprise. Revenue reached 77.07 thousand, compared to an expected --, with a 0.00% difference.
Looking ahead to Q4 25, -- analysts forecast an EPS of -0.06 USD, with revenue projected to reach -- USD, implying an increase of 0.00% EPS, and decrease of -100.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Navient Corporation 6% Senior Notes due December 15, 2043
Report Date
Jan 28, 2026 For Q4 25
Estimate
$0.32
Actual
$0.02
Surprise
-93.76%
Gladstone Investment Corporation 7.875% Notes due 2030
Report Date
Feb 03, 2026 For Q3 26
Estimate
$0.23
Actual
$0.21
Surprise
-10.18%
Gladstone Investment Corporation 4.875% Notes due 2028
Report Date
Feb 03, 2026 For Q3 26
Estimate
$0.23
Actual
$0.21
Surprise
-10.18%
NewtekOne, Inc. 5.50% Notes Due 2026
Report Date
Jan 29, 2026 For Q4 25
Estimate
$0.69
Actual
$0.65
Surprise
-6.52%
ConnectOne Bancorp, Inc. Depositary Shares
Report Date
Jan 29, 2026 For Q4 25
Estimate
$0.74
Actual
$0.83
Surprise
+11.77%
NewtekOne, Inc. 8.50% Fixed Rate Senior Notes due 2029
Report Date
Jan 29, 2026 For Q4 25
Estimate
$0.69
Actual
$0.65
Surprise
-6.52%
U-Haul Holding Company
Report Date
Feb 04, 2026 For Q3 26
Estimate
-$0.03
Actual
-$0.23
Surprise
-651.63%
NewtekOne, Inc. 8.00% Fixed Rate Senior Notes due 2028
Report Date
Jan 29, 2026 For Q4 25
Estimate
$0.69
Actual
$0.65
Surprise
-6.52%
First Internet Bancorp 6.0% Fixed-to-Floating Rate Subordinated Notes Due 2029
Report Date
Jan 29, 2026 For Q4 25
Estimate
$0.57
Actual
$0.64
Surprise
+10.61%
FAQ
What were NervGen Pharma Corp. Common stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, NervGen Pharma Corp. Common stock reported EPS of -$0.06, beating estimates by 0.99%, and revenue of $77.07K, 0% as expectations.
How did the market react to NervGen Pharma Corp. Common stock's Q3 2025 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is NervGen Pharma Corp. Common stock expected to report next?
The next earning report is scheduled for Apr 01, 2026.
What are the forecasts for NervGen Pharma Corp. Common stock's next earnings report?
Based on --
analysts, NervGen Pharma Corp. Common stock is expected to report EPS of -$0.06 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement